Loading...
•
Dec 31, 2021
Corcept Therapeutics Q4 2021 Earnings Report
Reported financial results for Q4 and full year 2021 and provided a corporate update.
Key Takeaways
Corcept Therapeutics reported Q4 2021 revenue of $98.8 million, compared to $85.7 million in Q4 2020. GAAP net income was $32.1 million, compared to $26.0 million in the same quarter of the previous year. The company anticipates 2022 revenue of $400 – $430 million.
Fourth quarter revenue was $98.8 million, compared to $85.7 million in fourth quarter 2020.
2021 revenue reached $366.0 million, compared to $353.9 million in 2020.
The company provided 2022 revenue guidance of $400 – $430 million.
Fourth quarter GAAP net income amounted to $32.1 million, compared to $26.0 million in fourth quarter 2020.